PMC:7445677 / 9471-9686 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T92","span":{"begin":40,"end":54},"obj":"Disease"}],"attributes":[{"id":"A92","pred":"mondo_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/MONDO_0005560"}],"text":"ndications for EEG testing as new-onset encephalopathy (68.2% vs 33.3%) and seizure-like events (14/22, 63.6%; 2/6, 33.3%). “Seizure-like” events were reported in patients without a prior history of seizures (11/17,"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T66","span":{"begin":19,"end":29},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T67","span":{"begin":100,"end":102},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T68","span":{"begin":180,"end":181},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T69","span":{"begin":209,"end":211},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"ndications for EEG testing as new-onset encephalopathy (68.2% vs 33.3%) and seizure-like events (14/22, 63.6%; 2/6, 33.3%). “Seizure-like” events were reported in patients without a prior history of seizures (11/17,"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T10","span":{"begin":15,"end":18},"obj":"Chemical"}],"attributes":[{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_73494"}],"text":"ndications for EEG testing as new-onset encephalopathy (68.2% vs 33.3%) and seizure-like events (14/22, 63.6%; 2/6, 33.3%). “Seizure-like” events were reported in patients without a prior history of seizures (11/17,"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"365","span":{"begin":163,"end":171},"obj":"Species"},{"id":"374","span":{"begin":40,"end":54},"obj":"Disease"},{"id":"375","span":{"begin":76,"end":83},"obj":"Disease"},{"id":"376","span":{"begin":125,"end":132},"obj":"Disease"},{"id":"377","span":{"begin":199,"end":207},"obj":"Disease"}],"attributes":[{"id":"A365","pred":"tao:has_database_id","subj":"365","obj":"Tax:9606"},{"id":"A374","pred":"tao:has_database_id","subj":"374","obj":"MESH:D001927"},{"id":"A375","pred":"tao:has_database_id","subj":"375","obj":"MESH:D012640"},{"id":"A376","pred":"tao:has_database_id","subj":"376","obj":"MESH:D012640"},{"id":"A377","pred":"tao:has_database_id","subj":"377","obj":"MESH:D012640"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ndications for EEG testing as new-onset encephalopathy (68.2% vs 33.3%) and seizure-like events (14/22, 63.6%; 2/6, 33.3%). “Seizure-like” events were reported in patients without a prior history of seizures (11/17,"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T69","span":{"begin":40,"end":54},"obj":"Phenotype"},{"id":"T70","span":{"begin":76,"end":83},"obj":"Phenotype"},{"id":"T71","span":{"begin":125,"end":132},"obj":"Phenotype"},{"id":"T72","span":{"begin":199,"end":207},"obj":"Phenotype"}],"attributes":[{"id":"A69","pred":"hp_id","subj":"T69","obj":"http://purl.obolibrary.org/obo/HP_0001298"},{"id":"A70","pred":"hp_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/HP_0001250"},{"id":"A71","pred":"hp_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/HP_0001250"},{"id":"A72","pred":"hp_id","subj":"T72","obj":"http://purl.obolibrary.org/obo/HP_0001250"}],"text":"ndications for EEG testing as new-onset encephalopathy (68.2% vs 33.3%) and seizure-like events (14/22, 63.6%; 2/6, 33.3%). “Seizure-like” events were reported in patients without a prior history of seizures (11/17,"}